New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


The Pipeline Gets the Cash as Zymeworks Trims 25% of Staff

Zymeworks provided a corporate update that included a string of clinical trial news. Additionally, 10 members of Zymeworks’ senior management team are leaving the clinical-stage biopharmaceutical company and the employee headcount will be cut by at least 25 percent by the end of 2022.


Study casts doubt on reliability of rapid antigen tests in kids; COVID transmission through breastmilk unlikely

When used in children, rapid antigen tests for detecting the coronavirus do not meet accuracy criteria set by the World Health Organization and U.S. and UK device regulators, according to researchers who reviewed 17 studies of the tests. Other research appears to confirm smaller, earlier studies that suggested nursing mothers are unlikely to transmit the coronavirus in breastmilk.